MARCHF7 and neoplasm: In addition, MARCH7 has been shown as a direct target of miR-27b-3p, so miR-27b-3p reduced the tumor-promoting impact of MARCH7. The above-mentioned findings suggest that MARCH7 is a tumor promoter factor, which could be a target in future EC therapy.